Comparison
Metformin vs Rapamycin
Metformin
Anti-diabetic medication studied for longevity. AMPK activator. Glucose normalization.
Rapamycin
mTOR inhibitor approved for immunosuppression after organ transplant. Studied off-label for longevity at low intermittent doses.
| Field | Metformin | Rapamycin |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 500–2000mg | 5–10mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEA |
| Safety | ●●●●○ | ●●○○○ |
| Legal (US) | USRx | USRx |
| PubMed refs | 23000 | 36000 |
Build a stack with bothOpen builder →
Check interactionsOpen checker →